1 Result(s)

Article

Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNα in patients with metastatic melanoma

The purpose of this study is to determine the toxicity and efficacy of temozolomide (TMZ) p.o. followed by subcutaneous (s.c.) low-dose interleukin-2 (IL2), granulocyte–monocyte colony stimulating factor (GM-C...

G C de Gast, D Batchelor, M J Kersten, F A Vyth-Dreese, J Sein… in British Journal of Cancer (2003)